Abstract
As quantitative neuroimaging continues to elucidate the gross neuropathology of schizophrenia, neurochemical and histological studies have contributed to defining this pathology in terms of neurotransmitter dysfunction. Increasingly, there is evidence implicating neurons containing the major inhibitory neurotransmitter of the brain — gamma-aminobutyric acid (GABA).
Benes was the first to demonstrate deficits in some morphological subtypes of interneurons in the frontal cortex in schizophrenia. We identified that this was specific to a subgroup of GABAergic interneurons containing parvalbumin (PV), which is found in the fast-firing cells providing inhibitory control of the cortico-fugal pyramidal cells. PV is notable in being expressed late in development; the late expression of this protective calcium binding protein (CBP) may impart an early vulnerability to these neurons, indicating a possible mechanism for the developmental origins of schizophrenia.
Cortical GABAergic neurons expressing the CBP calretinin (CR) are unaffected in schizophrenia, although those containing calbindin (CB) are also diminished in number. These deficits in PV and CB are notable in also being observed in bipolar disorder, indicating how the close aetiological relationship of these two psychiatric disorders is reflected in their pathology.
One of the most substantial abnormalities seen in post-mortem brain tissue is the hippocampal deficit of PV-containing neurons, again in the absence of effects on CR-positive cells. This deficit occurring in a structure implicated in cognitive symptomatology may well have functional relevance, and we find it can be induced by a model of the disease, subchronic phencyclidine (PCP) administration, that can also produce cognitive disturbances. This PCP model, like schizophrenia, demonstrates other neurochemical changes which include indicators of glutamatergic dysfunction. The temporal and aetiological relationships between glutamatergic and GABAergic deficits remains unclear, but may well relate to an initial loss/dysfunction of GABA/PV neurons that subsequently gives rise to a glutamatergic pathology.
Similar content being viewed by others
References
Abdul-Monim Z, GP Reynolds and JC Neill (2003) The atypical antipsychotic ziprasidone, but not haloperidol, improves PCP-induced cognitive deficits in a serial reversal learning task in the rat.J. Psychopharm. 17, 57–65.
Akbarian S, JJ Kim, SG Potkin, JO Hagman, A Tafazzoli, WE Bunney Jr and EG Jones (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in pre-frontal cortex of schizophrenics.Arch. Gen. Psychiatry 52, 258–266.
Beasley CL and GP Reynolds (1997) Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.Schizophr. Res. 24, 349–355.
Beasley CL, ZJ Zhang, I Patten and GP Reynolds (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium binding proteins.Biol. Psychiatry 52, 708–715.
Benes FM, J McSparren, ED Bird, JP SanGiovanni and SL Vincent (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.Arch. Gen. Psychiatry 48, 996–1001.
Benes FM, EW Kwok, SL Vincent and MS Todtenkopf (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.Biol. Psychiatry 44, 88–97.
Cochran SM, M Kennedy, CE McKerchar, LJ Steward, JA Pratt and BJ Morris (2003) Induction of metabolic hypofunction and neu-rochemical deficits after chronic intermittent exposure to phen-cyclidine: differential modulation by antipsychotic drugs.Neuropsychopharmacology 28, 265–275.
Cotter D, S Landau, RL Stevenson, CL Beasley, G Chana, L MacMillan and IP Everall (2002) The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.Biol. Psychiatry 51, 377–386.
Danos P, B Baumann, HG Bernstein, M Franz, R Stauch, G Northoff, D Krell, P Falkai and B Bogerts (1998) Schizophrenia and anteroventral thalamic nucleus: selective decrease of parval-bumin-immunoreactive thalamocortical projection neurons.Psychiatry Res. — Neuroimaging 82, 1–10.
Javitt DC and SR Zukin (1991) Recent advances in the phencycli-dine model of schizophrenia.Am. J. Psychiatry 148, 1301–1308.
Jentsch JD, A Tran, D Le, KD Youngren and RH Roth (1997) Sub-chronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.Neuropsychopharmacology 17, 92–99.
Olney JW and NB Farber (1995) Glutamate receptor dysfunction and schizophrenia.Arch. Gen. Psychiatry 52, 1015–1018.
Reynolds GP and CL Beasley (2001) GABAergic neuronal subtypes in the human frontal cortex — development and deficits in schizophrenia.J. Chem. Neuroanat. 22, 95–100.
Reynolds GP, ZJ Zhang and CL Beasley (2001) Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity.Brain Res. Bull. 55, 13–18.
Reynolds GP, CL Beasley and ZJ Zhang (2002) Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons.J. Neural Transm. 109, 881–889.
Solbach S and MR Celio (1991) Ontogeny of the calcium binding protein parvalbumin in the rat nervous system.Anat. Embryol. 184, 103–124.
Todtenkopf MS and FW Benes (1998) Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and non-pyramidal neurons in hippocampus of schizophrenic brain.Synapse 29, 323–332.
Woo TU, RE Whitehead, DS Melchitzky and DA Lewis (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia.Proc. Natl. Acad. Sci. USA 95, 5341–5346.
Zhang ZJ and GP Reynolds (2002) A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia.Schizophr. Res. 55, 1–10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reynolds, G.P., Abdul-Monim, Z., Neill, J.C. et al. Calcium binding protein markers of GABA deficits in schizophrenia — post mortem studies and animal models. neurotox res 6, 57–61 (2004). https://doi.org/10.1007/BF03033297
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033297